what are compounded glp-1 medications FDA says that the shortage is over Little Drugs - Agile Telehealth

The FDA has published safety concerns about compounded and unapproved GLP-1 products, including reports of adverse events and dosing errors

Between 2019 and December 2023 there has been a greater than 932% increase in prescriptions for semaglutide medications

The visible results of inflammation reduction include reduced facial puffiness, improved skin quality (clearer, more even tone, reduced redness), decreased joint swelling and pain, improved eye appearance (reduced under-eye bags and redness), and a general appearance of vitality that people describe as looking younger and healthier

Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: a meta-analysis of randomized placebo-controlled trials

What are the risks of off-label GLP-1 use given my medical history

Some trials show up to an 80% reduction in liver fat, with nearly 90% of individuals returning to healthy liver fat levels